Julio Rosenstock, MD is Director of Velocity Clinical Research at Medical City Dallas, and a Clinical Professor of Medicine at the University of Texas Southwestern Medical Center in Dallas. Dr. Rosenstock received his medical degree from the University of Costa Rica School of Medicine and completed fellowships in Endocrinology and Diabetes at the Royal Postgraduate Medical School Hammersmith Hospital in London, UK, and at the University of Texas Southwestern Medical Center. He is board certified in Internal Medicine as well as Endocrinology and Metabolism. His clinical and research activities have focused on exploring novel agents and therapeutic strategies to improve glycemic control, and particularly, early combination therapies in Type 2 Diabetes. Over the last 30 years, he has participated in hundreds of clinical trials and has had an active role in the development of new oral agents and insulin preparations, acting often as a lead clinical investigator and scientific advisor on the design and reporting of clinical trials on novel Diabetes drugs. Dr. Rosenstock has been the author or co-author of 349 peer-reviewed manuscripts (H-index 115) and several hundreds of scientific abstracts. He has also contributed to 13 book chapters on various topics in the field of diabetes and is considered a key opinion leader in Type 2 Diabetes. Dr. Rosenstock has also chaired or been a featured speaker at multiple lectures and presentations both nationally and internationally.
Julio Rosenstock, MD